|
DE19624659A1
(de)
|
1996-06-20 |
1998-01-08 |
Klinge Co Chem Pharm Fab |
Neue Pyridylalken- und Pyridylalkinsäureamide
|
|
US6451816B1
(en)
|
1997-06-20 |
2002-09-17 |
Klinge Pharma Gmbh |
Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
|
|
JPH10338658A
(ja)
*
|
1997-04-08 |
1998-12-22 |
Hoechst Marion Roussel Kk |
レチノイド作用調節剤
|
|
DE19756212A1
(de)
|
1997-12-17 |
1999-07-01 |
Klinge Co Chem Pharm Fab |
Neue, mit einem cyclischen Imid substituierte Pyridylalkan-, alken- und -alkincarbonsäureamide
|
|
DE19756235A1
(de)
|
1997-12-17 |
1999-07-01 |
Klinge Co Chem Pharm Fab |
Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide
|
|
US6903118B1
(en)
|
1997-12-17 |
2005-06-07 |
Klinge Pharma Gmbh |
Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
|
|
DE19756261A1
(de)
|
1997-12-17 |
1999-07-01 |
Klinge Co Chem Pharm Fab |
Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide
|
|
DE19818044A1
(de)
*
|
1998-04-22 |
1999-10-28 |
Klinge Co Chem Pharm Fab |
Verwendung von Vitamin-PP-Verbindungen
|
|
US6291459B1
(en)
*
|
1998-08-12 |
2001-09-18 |
Smithkline Beecham Corporation |
Calcilytic compounds
|
|
EP1031564A1
(en)
*
|
1999-02-26 |
2000-08-30 |
Klinge Pharma GmbH |
Inhibitors of cellular nicotinamide mononucleotide formation and their use in cancer therapy
|
|
DE19908483A1
(de)
*
|
1999-02-26 |
2000-10-05 |
Klinge Co Chem Pharm Fab |
Inhibitoren der zellulären Niacinamidmononucleotid-Bildung
|
|
ATE278421T1
(de)
*
|
2000-08-11 |
2004-10-15 |
Wyeth Corp |
Verfahren zur behandlung eines östrogenrezeptor positives karzinoms
|
|
IL155093A0
(en)
|
2000-09-29 |
2003-10-31 |
Glaxo Group Ltd |
Morpholin-acetamide derivatives for the treatment on inflammatory diseases
|
|
EP1348434A1
(en)
*
|
2002-03-27 |
2003-10-01 |
Fujisawa Deutschland GmbH |
Use of pyridyl amides as inhibitors of angiogenesis
|
|
GB0207445D0
(en)
*
|
2002-03-28 |
2002-05-08 |
Glaxo Group Ltd |
Novel compounds
|
|
US7977049B2
(en)
|
2002-08-09 |
2011-07-12 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
|
KR100927915B1
(ko)
|
2005-03-17 |
2009-11-19 |
화이자 인코포레이티드 |
통증 치료에 유용한 ｎ-(ｎ-설폰일아미노메틸)사이클로프로판카복사마이드 유도체
|
|
PE20071159A1
(es)
|
2005-10-31 |
2007-11-30 |
Schering Corp |
Derivados de tropano 3-monosustituido como ligandos de receptores de nociceptina
|
|
WO2007053499A2
(en)
|
2005-11-01 |
2007-05-10 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of ccr2
|
|
US8067457B2
(en)
|
2005-11-01 |
2011-11-29 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of CCR2
|
|
HUP0600809A3
(en)
*
|
2006-10-27 |
2008-09-29 |
Richter Gedeon Nyrt |
New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
|
|
EP2098231A1
(en)
|
2008-03-05 |
2009-09-09 |
Topotarget Switzerland SA |
Use of NAD formation inhibitors for the treatment of ischemia-reperfusion injury
|
|
WO2009156421A1
(en)
|
2008-06-24 |
2009-12-30 |
Topotarget A/S |
Squaric acid derivatives as inhibitors of the nicotinamide
|
|
JP5688367B2
(ja)
|
2008-08-29 |
2015-03-25 |
トポターゲット・アクティーゼルスカブＴｏｐｏＴａｒｇｅｔ Ａ／Ｓ |
新規なウレアおよびチオウレア誘導体
|
|
US20120270900A1
(en)
|
2009-07-17 |
2012-10-25 |
Topo Target A/S |
Novel method of treatment
|
|
WO2011121055A1
(en)
|
2010-03-31 |
2011-10-06 |
Topotarget A/S |
Pyridinyl derivatives comprising a cyanoguanidine or squaric acid moiety
|
|
AR082886A1
(es)
|
2010-09-03 |
2013-01-16 |
Forma Therapeutics Inc |
Compuestos y composiciones farmaceuticas que los contienen
|
|
SG188367A1
(en)
|
2010-09-03 |
2013-04-30 |
Forma Tm Llc |
Novel compounds and compositions for the inhibition of nampt
|
|
US20130273034A1
(en)
|
2010-09-03 |
2013-10-17 |
Kenneth W. Bair |
Novel compounds and compositions for the inhibition of nampt
|
|
ES2622881T3
(es)
*
|
2010-09-29 |
2017-07-07 |
Intervet International B.V. |
Compuestos de N-heteroarilo
|
|
EP2640704A1
(en)
|
2010-11-15 |
2013-09-25 |
Abbvie Inc. |
Nampt inhibitors
|
|
RU2013126657A
(ru)
|
2010-11-15 |
2014-12-27 |
Эббви Инк. |
Ингибиторы nampt и rock
|
|
AR082888A1
(es)
|
2011-05-04 |
2013-01-16 |
Forma Therapeutics Inc |
Compuestos de piridina para la inhibicion de nampt
|
|
CN106083886A
(zh)
|
2011-05-09 |
2016-11-09 |
福马Tm有限责任公司 |
用于抑制烟酰胺磷酸核糖基转移酶(nampt)的哌啶衍生物和组合物
|
|
CA2873075A1
(en)
|
2012-05-11 |
2013-07-14 |
Abbvie Inc. |
Nampt inhibitors
|
|
CN104271572A
(zh)
|
2012-05-11 |
2015-01-07 |
艾伯维公司 |
用作nampt抑制剂的噻唑羧酰胺衍生物
|
|
CN104583194A
(zh)
|
2012-05-11 |
2015-04-29 |
艾伯维公司 |
作为nampt抑制剂的哒嗪和吡啶衍生物
|
|
CN104428301A
(zh)
|
2012-05-11 |
2015-03-18 |
艾伯维公司 |
Nampt抑制剂
|
|
EP2925750A1
(en)
|
2012-11-29 |
2015-10-07 |
Karyopharm Therapeutics, Inc. |
Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
|
|
CA2917315C
(en)
|
2013-07-03 |
2021-10-05 |
Karyopharm Therapeutics Inc. |
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
|
|
US9994558B2
(en)
|
2013-09-20 |
2018-06-12 |
Karyopharm Therapeutics Inc. |
Multicyclic compounds and methods of using same
|
|
MA42655A
(fr)
|
2015-08-18 |
2021-04-07 |
Karyopharm Therapeutics Inc |
Acrylamide de (s,e)-3-(6-aminopyridin-3-yl)-n-((5-(4-(3-fluoro-3-méthylpyrrolidine-1-carbonyl)phényl)-7-(4-fluorophényl)benzofuran-2-yl)méthyl) pour le traitement du cancer
|
|
US10858347B2
(en)
|
2015-12-31 |
2020-12-08 |
Karyopharm Therapeutics Inc. |
Multicyclic compounds and uses thereof
|
|
MX2019004046A
(es)
|
2016-10-18 |
2019-08-21 |
Seattle Genetics Inc |
Administracion dirigida de inhibidores de la via de rescate de nicotinamida adenina dinucleotido.
|
|
WO2018086703A1
(en)
|
2016-11-11 |
2018-05-17 |
Bayer Pharma Aktiengesellschaft |
Dihydropyridazinones substituted with phenylureas
|
|
EP3615081A1
(en)
|
2017-04-27 |
2020-03-04 |
Seattle Genetics, Inc. |
Quaternized nicotinamide adenine dinucleotide salvage pathway inhibitor conjugates
|
|
JP2021512103A
(ja)
|
2018-01-31 |
2021-05-13 |
バイエル アクチェンゲゼルシャフトＢａｙｅｒ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｎａｍｐｔ阻害剤を含む抗体薬物複合体（ａｄｃｓ）
|
|
CN112312899B
(zh)
|
2018-05-04 |
2024-11-22 |
治疗方案股份有限公司 |
靶向癌症干细胞的癌症治疗
|
|
WO2021013693A1
(en)
|
2019-07-23 |
2021-01-28 |
Bayer Pharma Aktiengesellschaft |
Antibody drug conjugates (adcs) with nampt inhibitors
|
|
WO2021092322A1
(en)
|
2019-11-06 |
2021-05-14 |
Remedy Plan, Inc. |
Cancer treatments targeting cancer stem cells
|
|
WO2022241257A1
(en)
|
2021-05-13 |
2022-11-17 |
Remedy Plan, Inc. |
Nampt inhbitors and uses thereof
|